These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14694694)

  • 1. A case-control study on the effect of hormone replacement therapy on ischaemic heart disease.
    Hippisley-Cox J; Pringle M; Crown N; Coupland C
    Br J Gen Pract; 2003 Mar; 53(488):191-6. PubMed ID: 14694694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
    Chin BS; Futaba K; Jethwa A; Lip GY
    Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of hormone replacement therapy in Washington State: is prevention being put into practice?
    Saver BG; Taylor TR; Woods NF
    J Fam Pract; 1999 May; 48(5):364-71. PubMed ID: 10334613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hormone replacement therapy protective for venous ulcer of the lower limbs?
    Bérard A; Kahn SR; Abenhaim L
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):245-51. PubMed ID: 11501338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study.
    Douketis JD; Julian JA; Kearon C; Anderson DR; Crowther MA; Bates SM; Barone M; Piovella F; Turpie AG; Middeldorp S; van Nguyen P; Prandoni P; Wells PS; Kovacs MJ; MacGillavry MR; Costantini L; Ginsberg JS
    J Thromb Haemost; 2005 May; 3(5):943-8. PubMed ID: 15869589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
    Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
    Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
    Al-Farra HM; Al-Fahoum SK; Tabbaa MA
    Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy with estradiol and risk of venous thromboembolism--a population-based case-control study.
    Høibraaten E; Abdelnoor M; Sandset PM
    Thromb Haemost; 1999 Oct; 82(4):1218-21. PubMed ID: 10544901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Kotsopoulos J; Lubinski J; Neuhausen SL; Lynch HT; Rosen B; Ainsworth P; Moller P; Ghadirian P; Isaacs C; Karlan B; Sun P; Narod SA
    Gynecol Oncol; 2006 Jan; 100(1):83-8. PubMed ID: 16137751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy.
    Tavani A; Bertuzzi M; Gallus S; Negri E; La Vecchia C
    J Clin Epidemiol; 2005 Jul; 58(7):747-50. PubMed ID: 15939229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hormone replacement therapy on C-reactive protein: population-based data.
    Primatesta P; Falaschetti E; Poulter NR
    J Cardiovasc Risk; 2003 Feb; 10(1):57-60. PubMed ID: 12569237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.
    Corrao G; Zambon A; Nicotra F; Fornari C; La Vecchia C; Mezzanzanica M; Nappi RE; Merlino L; Cesana G
    Maturitas; 2007 Jul; 57(3):315-24. PubMed ID: 17485182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC
    Maturitas; 2007 May; 57(1):31-4. PubMed ID: 17383835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.
    Ramnath N; Menezes RJ; Loewen G; Dua P; Eid F; Alkhaddo J; Paganelli G; Natarajan N; Reid ME
    Oncology; 2007; 73(5-6):305-10. PubMed ID: 18493157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.